{"id": "article-27257_0", "title": "Pityriasis Rubra Pilaris -- Continuing Education Activity", "content": "Pityriasis rubra pilaris (PRP) is a rare inflammatory papulosquamous cutaneous disorder of unknown etiology.\u00a0PRP is commonly divided into 6 clinical subtypes in children and adults, including a genetic subtype.\u00a0Fundamental elements noted across all subtypes include palmoplantar keratoderma and follicular papules coalescing into well-demarcated reddish-orange plaques with a nonadherent scale.\u00a0More generalized subtypes classically demonstrate intervening areas of unaffected skin, known as \"islands of sparing.\"\u00a0Multiple subtypes often exhibit erythroderma covering \u226590% of the body surface area and have high levels of itch, skin tightness, burning, stinging, and pain.", "contents": "Pityriasis Rubra Pilaris -- Continuing Education Activity. Pityriasis rubra pilaris (PRP) is a rare inflammatory papulosquamous cutaneous disorder of unknown etiology.\u00a0PRP is commonly divided into 6 clinical subtypes in children and adults, including a genetic subtype.\u00a0Fundamental elements noted across all subtypes include palmoplantar keratoderma and follicular papules coalescing into well-demarcated reddish-orange plaques with a nonadherent scale.\u00a0More generalized subtypes classically demonstrate intervening areas of unaffected skin, known as \"islands of sparing.\"\u00a0Multiple subtypes often exhibit erythroderma covering \u226590% of the body surface area and have high levels of itch, skin tightness, burning, stinging, and pain."}
{"id": "article-27257_1", "title": "Pityriasis Rubra Pilaris -- Continuing Education Activity", "content": "Pityriasis rubra pilaris has a strong negative effect on quality of life, and those affected are at elevated risk for depression and suicidal ideation.\u00a0Treatment of pityriasis rubra pilaris can be challenging, but biologics have an emerging role in targeting the IL17/IL23 pathway. This activity\u00a0for healthcare professionals aims to enhance learners' competence in the appropriate diagnosis and management of\u00a0pityriasis rubra pilaris and highlights the\u00a0need\u00a0to\u00a0foster effective\u00a0interprofessional\u00a0teamwork\u00a0to improve patient outcomes.", "contents": "Pityriasis Rubra Pilaris -- Continuing Education Activity. Pityriasis rubra pilaris has a strong negative effect on quality of life, and those affected are at elevated risk for depression and suicidal ideation.\u00a0Treatment of pityriasis rubra pilaris can be challenging, but biologics have an emerging role in targeting the IL17/IL23 pathway. This activity\u00a0for healthcare professionals aims to enhance learners' competence in the appropriate diagnosis and management of\u00a0pityriasis rubra pilaris and highlights the\u00a0need\u00a0to\u00a0foster effective\u00a0interprofessional\u00a0teamwork\u00a0to improve patient outcomes."}
{"id": "article-27257_2", "title": "Pityriasis Rubra Pilaris -- Continuing Education Activity", "content": "Objectives: Assess the clinical presentation and histopathology in adults and children with presumed pityriasis rubra pilaris. Develop a therapeutic plan to manage\u00a0pityriasis rubra pilaris. Differentiate\u00a0pityriasis rubra pilaris from other papulosquamous disorders and other causes of erythroderma. Coordinate comprehensive care for individuals with\u00a0pityriasis rubra pilaris among interprofessional team members. Access free multiple choice questions on this topic.", "contents": "Pityriasis Rubra Pilaris -- Continuing Education Activity. Objectives: Assess the clinical presentation and histopathology in adults and children with presumed pityriasis rubra pilaris. Develop a therapeutic plan to manage\u00a0pityriasis rubra pilaris. Differentiate\u00a0pityriasis rubra pilaris from other papulosquamous disorders and other causes of erythroderma. Coordinate comprehensive care for individuals with\u00a0pityriasis rubra pilaris among interprofessional team members. Access free multiple choice questions on this topic."}
{"id": "article-27257_3", "title": "Pityriasis Rubra Pilaris -- Introduction", "content": "Pityriasis rubra pilaris (PRP) is a rare inflammatory papulosquamous disorder of unknown etiology. There are 6 clinical subtypes, which occur in both children and adults. Common elements noted across all subtypes include palmoplantar keratoderma and follicular papules coalescing into well-demarcated plaques of various sizes with characteristic reddish-orange hue and non-adherent, flaking scale. More generalized subtypes often demonstrate intervening areas of unaffected skin, known as \"islands of sparing,\" a signature characteristic of PRP. However, this feature may occasionally be found in PRP-mimickers (eg, psoriasis or mycosis fungoides), especially when these patients are erythrodermic.", "contents": "Pityriasis Rubra Pilaris -- Introduction. Pityriasis rubra pilaris (PRP) is a rare inflammatory papulosquamous disorder of unknown etiology. There are 6 clinical subtypes, which occur in both children and adults. Common elements noted across all subtypes include palmoplantar keratoderma and follicular papules coalescing into well-demarcated plaques of various sizes with characteristic reddish-orange hue and non-adherent, flaking scale. More generalized subtypes often demonstrate intervening areas of unaffected skin, known as \"islands of sparing,\" a signature characteristic of PRP. However, this feature may occasionally be found in PRP-mimickers (eg, psoriasis or mycosis fungoides), especially when these patients are erythrodermic."}
{"id": "article-27257_4", "title": "Pityriasis Rubra Pilaris -- Introduction", "content": "Patients with PRP have a broad spectrum of presentations, from mild disease isolated to extensor extremities to diffuse erythroderma involving 90% to 100% of body surface area, as well as intense itching, skin tightness, burning, stinging, and pain. In some cases, PRP is self-limited and asymptomatic; however, in symptomatic chronic cases, continued treatment is indicated, primarily consisting of topical treatments for symptomatic management and systemic therapy to reduce inflammation. [1] [2] [3] [4] [5]", "contents": "Pityriasis Rubra Pilaris -- Introduction. Patients with PRP have a broad spectrum of presentations, from mild disease isolated to extensor extremities to diffuse erythroderma involving 90% to 100% of body surface area, as well as intense itching, skin tightness, burning, stinging, and pain. In some cases, PRP is self-limited and asymptomatic; however, in symptomatic chronic cases, continued treatment is indicated, primarily consisting of topical treatments for symptomatic management and systemic therapy to reduce inflammation. [1] [2] [3] [4] [5]"}
{"id": "article-27257_5", "title": "Pityriasis Rubra Pilaris -- Etiology", "content": "The etiology of PRP remains elusive. PRP-like eruptions have been associated with some medications, especially ponatinib or other kinase inhibitors. [6] Although PRP has been temporally associated with viral infections, vaccinations, injuries, and other illnesses, these are not consistent, and distinguishing temporal associations from causality is difficult. There are multiple case reports associating PRP with malignancy, although the cutaneous manifestations of PRP in these cases tend to be atypical, and the range of associated tumors is varied. [7]", "contents": "Pityriasis Rubra Pilaris -- Etiology. The etiology of PRP remains elusive. PRP-like eruptions have been associated with some medications, especially ponatinib or other kinase inhibitors. [6] Although PRP has been temporally associated with viral infections, vaccinations, injuries, and other illnesses, these are not consistent, and distinguishing temporal associations from causality is difficult. There are multiple case reports associating PRP with malignancy, although the cutaneous manifestations of PRP in these cases tend to be atypical, and the range of associated tumors is varied. [7]"}
{"id": "article-27257_6", "title": "Pityriasis Rubra Pilaris -- Epidemiology", "content": "PRP occurs worldwide. Estimates of prevalence range from 1 in 500 new patient dermatology visits in Kenya to 1 in 5000 new dermatology visits in Great Britain to 1 in 50,000 new dermatology visits in India. [8] [9] [10] The prevalence of PRP between males and females is approximately equal, although some publications suggest a slight male predominance. [7] The onset\u00a0of PRP can occur at all ages, with slight bimodal peaks during the first to second and fifth to sixth decades of life. [11] Most cases appear to be sporadic, though familial cases also occur. The familial inheritance pattern\u00a0is usually autosomal dominant with gain-of-function gene variations found in CARD14. [12]", "contents": "Pityriasis Rubra Pilaris -- Epidemiology. PRP occurs worldwide. Estimates of prevalence range from 1 in 500 new patient dermatology visits in Kenya to 1 in 5000 new dermatology visits in Great Britain to 1 in 50,000 new dermatology visits in India. [8] [9] [10] The prevalence of PRP between males and females is approximately equal, although some publications suggest a slight male predominance. [7] The onset\u00a0of PRP can occur at all ages, with slight bimodal peaks during the first to second and fifth to sixth decades of life. [11] Most cases appear to be sporadic, though familial cases also occur. The familial inheritance pattern\u00a0is usually autosomal dominant with gain-of-function gene variations found in CARD14. [12]"}
{"id": "article-27257_7", "title": "Pityriasis Rubra Pilaris -- Pathophysiology", "content": "Inherited PRP, which usually presents before age 2, is associated with gain-of-function gene variations in CARD14 , found in the psoriasis susceptibility locus 2 ( PSORS2 ), a gene that activates Nuclear Factor-kappa B (NFkB). [12] Occasionally, these gene variations have also been noted in patients with sporadic adult-onset PRP. [13] CARD14 gene variations are also found in familial psoriasis, highlighting the overlap between PRP and psoriasis. [14]", "contents": "Pityriasis Rubra Pilaris -- Pathophysiology. Inherited PRP, which usually presents before age 2, is associated with gain-of-function gene variations in CARD14 , found in the psoriasis susceptibility locus 2 ( PSORS2 ), a gene that activates Nuclear Factor-kappa B (NFkB). [12] Occasionally, these gene variations have also been noted in patients with sporadic adult-onset PRP. [13] CARD14 gene variations are also found in familial psoriasis, highlighting the overlap between PRP and psoriasis. [14]"}
{"id": "article-27257_8", "title": "Pityriasis Rubra Pilaris -- Pathophysiology", "content": "Like psoriasis, classical PRP is associated with activation of the Th17/IL23 inflammatory pathways. [15] [16] Transgenic mouse models that recapitulate the epidermal CARD14 gene variations found in PRP and psoriasis caused induction of NFkB and activation of the IL23-IL17A cytokine axis, [17] [18] suggesting that genetic and sporadic PRP have similar underlying inflammatory pathways. Transcriptomics comparison between skin from patients with psoriasis and PRP showed a complete overlap of dysregulated genes, such that all significantly dysregulated genes in PRP were also found in psoriasis skin, further highlighting the shared pathophysiology between PRP and psoriasis. [19]", "contents": "Pityriasis Rubra Pilaris -- Pathophysiology. Like psoriasis, classical PRP is associated with activation of the Th17/IL23 inflammatory pathways. [15] [16] Transgenic mouse models that recapitulate the epidermal CARD14 gene variations found in PRP and psoriasis caused induction of NFkB and activation of the IL23-IL17A cytokine axis, [17] [18] suggesting that genetic and sporadic PRP have similar underlying inflammatory pathways. Transcriptomics comparison between skin from patients with psoriasis and PRP showed a complete overlap of dysregulated genes, such that all significantly dysregulated genes in PRP were also found in psoriasis skin, further highlighting the shared pathophysiology between PRP and psoriasis. [19]"}
{"id": "article-27257_9", "title": "Pityriasis Rubra Pilaris -- Histopathology", "content": "PRP classically presents with irregular, psoriasiform acanthosis of the epidermis and a characteristic overlying \"checkerboard\" pattern of parakeratosis, alternating vertical and horizontal ortho- and parakeratosis.\u00a0Follicular plugging with shoulder parakeratosis is often noted also. Findings of thick, rather than thin, suprapapillary plates and lack of neutrophils in the stratum corneum may help distinguish PRP from psoriasis. Typically, with PRP, the granular layer is normal or thickened under areas of parakeratosis on histologic evaluation. Furthermore, variable mild superficial perivascular lymphohistiocytic infiltrate, occasional mild epidermal spongiosis, eosinophils,\u00a0and focal acantholytic dyskeratosis, which histopathologically resembles Grover's disease, have been reported but are not consistently found. [20] While acantholysis may be seen in <25% of cases, this finding can further help distinguish PRP from psoriasis. [21]", "contents": "Pityriasis Rubra Pilaris -- Histopathology. PRP classically presents with irregular, psoriasiform acanthosis of the epidermis and a characteristic overlying \"checkerboard\" pattern of parakeratosis, alternating vertical and horizontal ortho- and parakeratosis.\u00a0Follicular plugging with shoulder parakeratosis is often noted also. Findings of thick, rather than thin, suprapapillary plates and lack of neutrophils in the stratum corneum may help distinguish PRP from psoriasis. Typically, with PRP, the granular layer is normal or thickened under areas of parakeratosis on histologic evaluation. Furthermore, variable mild superficial perivascular lymphohistiocytic infiltrate, occasional mild epidermal spongiosis, eosinophils,\u00a0and focal acantholytic dyskeratosis, which histopathologically resembles Grover's disease, have been reported but are not consistently found. [20] While acantholysis may be seen in <25% of cases, this finding can further help distinguish PRP from psoriasis. [21]"}
{"id": "article-27257_10", "title": "Pityriasis Rubra Pilaris -- History and Physical", "content": "The clinical spectrum of PRP was initially divided into 5 subtypes using a widely accepted classification scheme proposed by Griffiths in 1980, based on the onset (ie, childhood versus adult), lesion characteristics, and distribution. [10] Griffiths also suggested that these clinical subtypes were predictive of clinical prognosis, but these predictions were not validated and have not been held in clinical trials. [22] [23] A sixth subtype was added due to reports of association with HIV. [24] [25] Finally, patients with early-onset PRP associated with CARD14 gene variations have been proposed as a separate entity, entitled CARD14-associated papulosquamous eruption (CAPE). [26] The following are the subtypes of PRP: Type I: classical adult-onset Type II: atypical adult-onset Type III: classical juvenile-onset Type IV: circumscribed juvenile-onset Type V: atypical juvenile-onset Type VI: HIV-associated CARD14-associated papulosquamous eruption (CAPE)", "contents": "Pityriasis Rubra Pilaris -- History and Physical. The clinical spectrum of PRP was initially divided into 5 subtypes using a widely accepted classification scheme proposed by Griffiths in 1980, based on the onset (ie, childhood versus adult), lesion characteristics, and distribution. [10] Griffiths also suggested that these clinical subtypes were predictive of clinical prognosis, but these predictions were not validated and have not been held in clinical trials. [22] [23] A sixth subtype was added due to reports of association with HIV. [24] [25] Finally, patients with early-onset PRP associated with CARD14 gene variations have been proposed as a separate entity, entitled CARD14-associated papulosquamous eruption (CAPE). [26] The following are the subtypes of PRP: Type I: classical adult-onset Type II: atypical adult-onset Type III: classical juvenile-onset Type IV: circumscribed juvenile-onset Type V: atypical juvenile-onset Type VI: HIV-associated CARD14-associated papulosquamous eruption (CAPE)"}
{"id": "article-27257_11", "title": "Pityriasis Rubra Pilaris -- History and Physical", "content": "The cardinal features across subtypes include palmoplantar hyperkeratosis and hyperkeratotic follicular papules coalescing into well-demarcated red-orange plaques. (see Image .\u00a0Pityriasis Rubra Pilaris). Limited or circumscribed variants may be only mildly pruritic. In contrast, widespread PRP is associated with severe pruritus and pain interfering with activities of daily living and quality of life and an increased risk of suicidal ideation. [27] [28] [3] (see Image . Severe\u00a0Pityriasis Rubra Pilaris).", "contents": "Pityriasis Rubra Pilaris -- History and Physical. The cardinal features across subtypes include palmoplantar hyperkeratosis and hyperkeratotic follicular papules coalescing into well-demarcated red-orange plaques. (see Image .\u00a0Pityriasis Rubra Pilaris). Limited or circumscribed variants may be only mildly pruritic. In contrast, widespread PRP is associated with severe pruritus and pain interfering with activities of daily living and quality of life and an increased risk of suicidal ideation. [27] [28] [3] (see Image . Severe\u00a0Pityriasis Rubra Pilaris)."}
{"id": "article-27257_12", "title": "Pityriasis Rubra Pilaris -- History and Physical -- Type I Classical Adult Pityriasis Rubra Pilaris", "content": "Type I PRP affects 55% of patients and is the most common in adults. [10] The classic sequence of signs in type I PRP begins with a fine scale and erythema on the scalp, which may be initially mistaken for seborrheic dermatitis. Small groups of follicular hyperkeratotic papules may be noted on the dorsal fingers or the head and neck. Various terms, including \u201cnutmeg grater\u201d or \u201cexaggerated gooseflesh,\u201d have been used to describe these grid-line arrays of follicular-based papules.(see Image .\u00a0Pityriasis Rubra Pilaris Lesions). Within weeks to a few months, more papules erupt and coalesce into plaques that progress in a cephalocaudal manner.\u00a0Involved skin is often sharply demarcated from adjacent uninvolved skin, producing a characteristic phenomenon termed \u201cislands of sparing.\u201d\u00a0(see Image .\u00a0Islands of Sparing in\u00a0Pityriasis Rubra Pilaris).", "contents": "Pityriasis Rubra Pilaris -- History and Physical -- Type I Classical Adult Pityriasis Rubra Pilaris. Type I PRP affects 55% of patients and is the most common in adults. [10] The classic sequence of signs in type I PRP begins with a fine scale and erythema on the scalp, which may be initially mistaken for seborrheic dermatitis. Small groups of follicular hyperkeratotic papules may be noted on the dorsal fingers or the head and neck. Various terms, including \u201cnutmeg grater\u201d or \u201cexaggerated gooseflesh,\u201d have been used to describe these grid-line arrays of follicular-based papules.(see Image .\u00a0Pityriasis Rubra Pilaris Lesions). Within weeks to a few months, more papules erupt and coalesce into plaques that progress in a cephalocaudal manner.\u00a0Involved skin is often sharply demarcated from adjacent uninvolved skin, producing a characteristic phenomenon termed \u201cislands of sparing.\u201d\u00a0(see Image .\u00a0Islands of Sparing in\u00a0Pityriasis Rubra Pilaris)."}
{"id": "article-27257_13", "title": "Pityriasis Rubra Pilaris -- History and Physical -- Type I Classical Adult Pityriasis Rubra Pilaris", "content": "The disease often progresses into diffuse erythrodermic plaques, in which the follicular papules are no longer visible. [29] (see Image .\u00a0Pityriasis Rubra Pilaris With Erythroderma.) The epidermal scale is fine and nonadherent, termed pityriasiform or furfuraceous scaling, although it may be thicker and more adherent on the face and scalp.\u00a0In deeply pigmented skin, the characteristics lesions of PRP appear hyperpigmented with subtle dark red to violaceous erythema.\u00a0(see Image .\u00a0Pityriasis Rubra Pilaris of the Dorsal Foot). In lightly pigmented skin, the lesions are pink-red to salmon-orange.\u00a0Dermoscopy may reveal a keratotic whitish plug with central hair and surrounding yellow-pink to dark brown halo with dotted vessels. [30] Palmoplantar keratoderma (PPK) is another characteristic finding in PRP and classically has a unique waxy red-orange or bright yellow color. Nail involvement is common, with subungual hyperkeratosis, splinter hemorrhages, and longitudinal ridging.\u00a0(see Image . Pityriasis Rubra Pilaris with Keratoderma). Eruptive seborrheic keratoses are occasionally found in erythrodermic PRP; these have not been associated with malignancy, as would be considered in the sign of Leser-Trelat. [31] [32] During the resolution phase of PRP, cutaneous plaques may form an erythema gyratum repens-like morphology, with parallel arcuate rings resembling wood grain. This likewise has not been associated with malignancy when it occurs in association with PRP, as compared with true erythema gyratum repens, which often is a sign of underlying malignancy. [33] (see Image . Gyratum-Repens Like\u00a0Pityriasis Rubra Pilaris).", "contents": "Pityriasis Rubra Pilaris -- History and Physical -- Type I Classical Adult Pityriasis Rubra Pilaris. The disease often progresses into diffuse erythrodermic plaques, in which the follicular papules are no longer visible. [29] (see Image .\u00a0Pityriasis Rubra Pilaris With Erythroderma.) The epidermal scale is fine and nonadherent, termed pityriasiform or furfuraceous scaling, although it may be thicker and more adherent on the face and scalp.\u00a0In deeply pigmented skin, the characteristics lesions of PRP appear hyperpigmented with subtle dark red to violaceous erythema.\u00a0(see Image .\u00a0Pityriasis Rubra Pilaris of the Dorsal Foot). In lightly pigmented skin, the lesions are pink-red to salmon-orange.\u00a0Dermoscopy may reveal a keratotic whitish plug with central hair and surrounding yellow-pink to dark brown halo with dotted vessels. [30] Palmoplantar keratoderma (PPK) is another characteristic finding in PRP and classically has a unique waxy red-orange or bright yellow color. Nail involvement is common, with subungual hyperkeratosis, splinter hemorrhages, and longitudinal ridging.\u00a0(see Image . Pityriasis Rubra Pilaris with Keratoderma). Eruptive seborrheic keratoses are occasionally found in erythrodermic PRP; these have not been associated with malignancy, as would be considered in the sign of Leser-Trelat. [31] [32] During the resolution phase of PRP, cutaneous plaques may form an erythema gyratum repens-like morphology, with parallel arcuate rings resembling wood grain. This likewise has not been associated with malignancy when it occurs in association with PRP, as compared with true erythema gyratum repens, which often is a sign of underlying malignancy. [33] (see Image . Gyratum-Repens Like\u00a0Pityriasis Rubra Pilaris)."}
{"id": "article-27257_14", "title": "Pityriasis Rubra Pilaris -- History and Physical -- Type I Classical Adult Pityriasis Rubra Pilaris", "content": "Noncutaneous complications of widespread or erythrodermic PRP include ectropion of the lower eyelids that occasionally results in keratitis, the buildup of wax and scale in the external auditory canals that may muffle hearing, rhinorrhea, hair loss, edema of the limbs, anhidrosis (ie, lack of sweating), and difficulty with body temperature regulation.\u00a0Common physical symptoms of widespread PRP include severe pruritus, a burning sensation in the involved skin, painful palmoplantar fissures, arthralgias, poor sleep, and fatigue. These symptoms may lead to loss of fine motor ability, difficulty walking, difficulty wearing regular clothing due to dysesthesia, and difficulty leaving the home.\u00a0Common mental health impacts reported by people with severe PRP include depression, anxiety, embarrassment, loneliness, loss of self-esteem, memory loss or brain fog, and passive or active suicidal ideation. [27]", "contents": "Pityriasis Rubra Pilaris -- History and Physical -- Type I Classical Adult Pityriasis Rubra Pilaris. Noncutaneous complications of widespread or erythrodermic PRP include ectropion of the lower eyelids that occasionally results in keratitis, the buildup of wax and scale in the external auditory canals that may muffle hearing, rhinorrhea, hair loss, edema of the limbs, anhidrosis (ie, lack of sweating), and difficulty with body temperature regulation.\u00a0Common physical symptoms of widespread PRP include severe pruritus, a burning sensation in the involved skin, painful palmoplantar fissures, arthralgias, poor sleep, and fatigue. These symptoms may lead to loss of fine motor ability, difficulty walking, difficulty wearing regular clothing due to dysesthesia, and difficulty leaving the home.\u00a0Common mental health impacts reported by people with severe PRP include depression, anxiety, embarrassment, loneliness, loss of self-esteem, memory loss or brain fog, and passive or active suicidal ideation. [27]"}
{"id": "article-27257_15", "title": "Pityriasis Rubra Pilaris -- History and Physical -- Type II Atypical Adult\u00a0Pityriasis Rubra Pilaris", "content": "Type II PRP reportedly affects 5% of patients with PRP. [10] Clinical findings of type II PRP may be similar to those in classical PRP but with more eczematous plaques, ichthyosiform scale, especially on the lower extremities, coarse laminated palmoplantar keratoderma, and more pronounced alopecia.\u00a0(see Image . Pityriasis Rubra Pilaris With Atypical Ichthyosiform Scale). Care must be taken when making this diagnosis since, clinically, it has a substantial overlap with erythrodermic mycosis fungoides, Sezary syndrome, and paraneoplastic phenomena. [34]", "contents": "Pityriasis Rubra Pilaris -- History and Physical -- Type II Atypical Adult\u00a0Pityriasis Rubra Pilaris. Type II PRP reportedly affects 5% of patients with PRP. [10] Clinical findings of type II PRP may be similar to those in classical PRP but with more eczematous plaques, ichthyosiform scale, especially on the lower extremities, coarse laminated palmoplantar keratoderma, and more pronounced alopecia.\u00a0(see Image . Pityriasis Rubra Pilaris With Atypical Ichthyosiform Scale). Care must be taken when making this diagnosis since, clinically, it has a substantial overlap with erythrodermic mycosis fungoides, Sezary syndrome, and paraneoplastic phenomena. [34]"}
{"id": "article-27257_16", "title": "Pityriasis Rubra Pilaris -- History and Physical -- Type III Classic Juvenile Pityriasis Rubra Pilaris", "content": "Type III PRP comprises 10% of cases and is similar to type I classical adult PRP but has a juvenile onset and less commonly results in erythroderma. Palmoplantar keratoderma with scalp, face, and upper trunk involvement is most common. [35] [36] [37]", "contents": "Pityriasis Rubra Pilaris -- History and Physical -- Type III Classic Juvenile Pityriasis Rubra Pilaris. Type III PRP comprises 10% of cases and is similar to type I classical adult PRP but has a juvenile onset and less commonly results in erythroderma. Palmoplantar keratoderma with scalp, face, and upper trunk involvement is most common. [35] [36] [37]"}
{"id": "article-27257_17", "title": "Pityriasis Rubra Pilaris -- History and Physical -- Type IV Circumscribed Juvenile Pityriasis Rubra Pilaris", "content": "Type IV PRP is the only focal variant. [35] [36] [37] This is the most common subtype of juvenile PRP and most commonly occurs in prepubertal children. Sharply demarcated grouped follicular papules on an erythematous base are commonly found on the extensor elbows, knees, Achilles tendon, and other bony prominences. Follicular papules may be variably scattered across other body areas. Palmoplantar keratoderma is also present.", "contents": "Pityriasis Rubra Pilaris -- History and Physical -- Type IV Circumscribed Juvenile Pityriasis Rubra Pilaris. Type IV PRP is the only focal variant. [35] [36] [37] This is the most common subtype of juvenile PRP and most commonly occurs in prepubertal children. Sharply demarcated grouped follicular papules on an erythematous base are commonly found on the extensor elbows, knees, Achilles tendon, and other bony prominences. Follicular papules may be variably scattered across other body areas. Palmoplantar keratoderma is also present."}
{"id": "article-27257_18", "title": "Pityriasis Rubra Pilaris -- History and Physical -- Type V Atypical Juvenile Pityriasis Rubra Pilaris", "content": "Type V PRP is a chronic, generalized juvenile variant affecting 5% of patients. Griffiths described it in children in the first few years of life, with follicular hyperkeratosis, less prominent erythema, and occasional scleroderma-like changes of the hands. Type V PRP is sometimes used to describe all cases of inherited PRP, although others have proposed that many of these cases be recategorized as CAPE. Griffiths and others have suggested that some Type V PRP cases may represent atypical follicular ichthyosis. [38]", "contents": "Pityriasis Rubra Pilaris -- History and Physical -- Type V Atypical Juvenile Pityriasis Rubra Pilaris. Type V PRP is a chronic, generalized juvenile variant affecting 5% of patients. Griffiths described it in children in the first few years of life, with follicular hyperkeratosis, less prominent erythema, and occasional scleroderma-like changes of the hands. Type V PRP is sometimes used to describe all cases of inherited PRP, although others have proposed that many of these cases be recategorized as CAPE. Griffiths and others have suggested that some Type V PRP cases may represent atypical follicular ichthyosis. [38]"}
{"id": "article-27257_19", "title": "Pityriasis Rubra Pilaris -- History and Physical -- Type VI HIV-associated Pityriasis Rubra Pilaris", "content": "Type VI PRP occurs concurrently with HIV. Relatively few case reports have been published, so a causal association is not clear, although the relative immune dysregulation in HIV may link the two entities. PRP has been reported in individuals with both well-controlled HIV and poorly controlled HIV/AIDS. With PRP, hidradenitis suppurativa, acne conglobata, and lichen spinulosus, a follicular occlusion syndrome has also been described. [39]", "contents": "Pityriasis Rubra Pilaris -- History and Physical -- Type VI HIV-associated Pityriasis Rubra Pilaris. Type VI PRP occurs concurrently with HIV. Relatively few case reports have been published, so a causal association is not clear, although the relative immune dysregulation in HIV may link the two entities. PRP has been reported in individuals with both well-controlled HIV and poorly controlled HIV/AIDS. With PRP, hidradenitis suppurativa, acne conglobata, and lichen spinulosus, a follicular occlusion syndrome has also been described. [39]"}
{"id": "article-27257_20", "title": "Pityriasis Rubra Pilaris -- History and Physical -- CARD14-Associated Papulosquamous Eruption", "content": "CARD14-associated papulosquamous eruption (CAPE)\u00a0presents in children in the first 2 years of life with a gene variation in CARD14. [26] Inheritance is autosomal dominant. CAPE may present clinically as classical psoriasis, classical PRP, or a hybrid. Erythema of the cheeks, chin, and ears is common. (see Image .\u00a0Facial\u00a0Pityriasis Rubra Pilaris). Sclerodermoid changes of the hands are occasionally found, as described in Griffiths type V PRP, but are not present in most individuals.", "contents": "Pityriasis Rubra Pilaris -- History and Physical -- CARD14-Associated Papulosquamous Eruption. CARD14-associated papulosquamous eruption (CAPE)\u00a0presents in children in the first 2 years of life with a gene variation in CARD14. [26] Inheritance is autosomal dominant. CAPE may present clinically as classical psoriasis, classical PRP, or a hybrid. Erythema of the cheeks, chin, and ears is common. (see Image .\u00a0Facial\u00a0Pityriasis Rubra Pilaris). Sclerodermoid changes of the hands are occasionally found, as described in Griffiths type V PRP, but are not present in most individuals."}
{"id": "article-27257_21", "title": "Pityriasis Rubra Pilaris -- Evaluation", "content": "A complete cutaneous exam should be performed, with palpation for lymphadenopathy that might indicate malignancy and thus an alternate diagnosis, especially in adults. If present, at least\u00a02 cutaneous biopsies are recommended to capture follicular papules or scaly erythematous plaques. PRP is diagnosed based on clinical and histopathological features. Studies have not identified serologic or immunohistochemical markers to assist in the diagnosis. Due to the rare association with HIV, screening should be considered.", "contents": "Pityriasis Rubra Pilaris -- Evaluation. A complete cutaneous exam should be performed, with palpation for lymphadenopathy that might indicate malignancy and thus an alternate diagnosis, especially in adults. If present, at least\u00a02 cutaneous biopsies are recommended to capture follicular papules or scaly erythematous plaques. PRP is diagnosed based on clinical and histopathological features. Studies have not identified serologic or immunohistochemical markers to assist in the diagnosis. Due to the rare association with HIV, screening should be considered."}
{"id": "article-27257_22", "title": "Pityriasis Rubra Pilaris -- Treatment / Management", "content": "The treatment of PRP can be challenging, and there are currently no US Food and Drug Administration-approved treatments.\u00a0All patients may benefit symptomatically from frequently applying bland cream or ointment-based emollients daily or frequently throughout the day, as needed, for comfort and skin barrier repair. Topical corticosteroids may not always show benefit over bland emollients. However, a 2-week trial of a mid-potency topical steroid for the body and a high-potency topical steroid for the hands and feet can be tried. Keratolytic agents, such as urea, salicylic acid, or alpha-hydroxy acid-containing preparations, can be helpful for thick palmoplantar keratoderma, especially under occlusion with gloves for the hands and booties (eg, neoprene scuba socks) for the feet.", "contents": "Pityriasis Rubra Pilaris -- Treatment / Management. The treatment of PRP can be challenging, and there are currently no US Food and Drug Administration-approved treatments.\u00a0All patients may benefit symptomatically from frequently applying bland cream or ointment-based emollients daily or frequently throughout the day, as needed, for comfort and skin barrier repair. Topical corticosteroids may not always show benefit over bland emollients. However, a 2-week trial of a mid-potency topical steroid for the body and a high-potency topical steroid for the hands and feet can be tried. Keratolytic agents, such as urea, salicylic acid, or alpha-hydroxy acid-containing preparations, can be helpful for thick palmoplantar keratoderma, especially under occlusion with gloves for the hands and booties (eg, neoprene scuba socks) for the feet."}
{"id": "article-27257_23", "title": "Pityriasis Rubra Pilaris -- Treatment / Management", "content": "In patients with widespread PRP, a waterproof PVC or coated nylon\u00a0\u201csauna suit\u201d can be helpful for body temperature dysregulation, occlusion of the skin barrier, and skin dysesthesia from clothing intolerance. Bathing should be as often as tolerated; some individuals with PRP find comfort from long, tepid baths, and others cannot tolerate the feeling of water on the skin.", "contents": "Pityriasis Rubra Pilaris -- Treatment / Management. In patients with widespread PRP, a waterproof PVC or coated nylon\u00a0\u201csauna suit\u201d can be helpful for body temperature dysregulation, occlusion of the skin barrier, and skin dysesthesia from clothing intolerance. Bathing should be as often as tolerated; some individuals with PRP find comfort from long, tepid baths, and others cannot tolerate the feeling of water on the skin."}
{"id": "article-27257_24", "title": "Pityriasis Rubra Pilaris -- Treatment / Management", "content": "For patients with moderate-to-severe PRP,\u00a0systemic therapy is recommended. No randomized controlled trials have been performed in PRP. Only 3 systematic open-label trials have been published; these trials studied high-dose isotretinoin,\u00a0ixekizumab,\u00a0and secukinumab. [22] [23] [40] [41] [40] [23] In a 1982 study, isotretinoin was given to 45 adults and children with PRP at an average dose of 2.13 mg/kg/day, and 26 subjects\u00a0(58%) clearly improved after 4 weeks. [41] A recent meta-analysis reported that isotretinoin is associated with a 61.1% excellent response rate. [42] However, high-dose isotretinoin is difficult to tolerate due to severe xerosis and cheilitis, myalgias, elevations in liver function tests, elevated triglycerides, and a high risk of congenital disabilities. Targeted biologics may be preferred, given the emerging role of the IL17/IL23 axis in PRP. Ixekizumab, a biologic IL17A inhibitor, was given to adults with moderate-to-severe PRP and resulted in a mean 61.3% improvement in clinical severity after 24 weeks, with no serious adverse events. [22]", "contents": "Pityriasis Rubra Pilaris -- Treatment / Management. For patients with moderate-to-severe PRP,\u00a0systemic therapy is recommended. No randomized controlled trials have been performed in PRP. Only 3 systematic open-label trials have been published; these trials studied high-dose isotretinoin,\u00a0ixekizumab,\u00a0and secukinumab. [22] [23] [40] [41] [40] [23] In a 1982 study, isotretinoin was given to 45 adults and children with PRP at an average dose of 2.13 mg/kg/day, and 26 subjects\u00a0(58%) clearly improved after 4 weeks. [41] A recent meta-analysis reported that isotretinoin is associated with a 61.1% excellent response rate. [42] However, high-dose isotretinoin is difficult to tolerate due to severe xerosis and cheilitis, myalgias, elevations in liver function tests, elevated triglycerides, and a high risk of congenital disabilities. Targeted biologics may be preferred, given the emerging role of the IL17/IL23 axis in PRP. Ixekizumab, a biologic IL17A inhibitor, was given to adults with moderate-to-severe PRP and resulted in a mean 61.3% improvement in clinical severity after 24 weeks, with no serious adverse events. [22]"}
{"id": "article-27257_25", "title": "Pityriasis Rubra Pilaris -- Treatment / Management", "content": "In the clinician-measured Psoriasis Area and Severity Index (PASI75), 5 of 11 participants (45%) had\u00a0\u226575% improvement. Similarly, secukinumab, another biologic IL17A inhibitor, was given to adults with moderate-to-severe PRP and resulted in a mean 55.6% improvement in clinical severity after 28 weeks and no serious adverse events in 6 of 11 participants with PASI75 (55%). [23] Ustekinumab has shown benefit in case series of children with CAPE. [26] Of important note, oral corticosteroids (eg, prednisone) are not effective for PRP, and this has been suggested to have diagnostic relevance since most other forms of erythroderma have at least partial improvement with oral corticosteroids. [42] [43]", "contents": "Pityriasis Rubra Pilaris -- Treatment / Management. In the clinician-measured Psoriasis Area and Severity Index (PASI75), 5 of 11 participants (45%) had\u00a0\u226575% improvement. Similarly, secukinumab, another biologic IL17A inhibitor, was given to adults with moderate-to-severe PRP and resulted in a mean 55.6% improvement in clinical severity after 28 weeks and no serious adverse events in 6 of 11 participants with PASI75 (55%). [23] Ustekinumab has shown benefit in case series of children with CAPE. [26] Of important note, oral corticosteroids (eg, prednisone) are not effective for PRP, and this has been suggested to have diagnostic relevance since most other forms of erythroderma have at least partial improvement with oral corticosteroids. [42] [43]"}
{"id": "article-27257_26", "title": "Pityriasis Rubra Pilaris -- Treatment / Management", "content": "Historically, methotrexate and acitretin have been suggested as first-line systemic therapy for PRP. While no systematic trials have been performed for these medications, systematic reviews suggest lower efficacy rates compared to the trials above. A very good response was reported to acitretin in 36% and methotrexate in 35% of patients in one review,\u00a0and an excellent response was reported to oral retinoids in 42% and methotrexate in 33% of patients in another review. [43] [42] The actual rates may be lower still since the data were collected from case series and case reports, increasing the risk of publication bias.\u00a0Other systemic immunomodulators have been reported to benefit PRP in case reports and small case series. These include additional IL17 inhibitors brodalumab\u00a0and bimekizumab;\u00a0the IL23 inhibitors guselkumab,\u00a0risankizumab,\u00a0and tildrakizumab;\u00a0the TNF-alpha inhibitors adalimumab,\u00a0etanercept,\u00a0and infliximab;\u00a0the phosphodiesterase 4 inhibitor apremilast;\u00a0and the JAK inhibitors tofacitinib\u00a0and upadacitinib. [44] [45] [46] [47] [48] [49] [50] [51] [52] [53]", "contents": "Pityriasis Rubra Pilaris -- Treatment / Management. Historically, methotrexate and acitretin have been suggested as first-line systemic therapy for PRP. While no systematic trials have been performed for these medications, systematic reviews suggest lower efficacy rates compared to the trials above. A very good response was reported to acitretin in 36% and methotrexate in 35% of patients in one review,\u00a0and an excellent response was reported to oral retinoids in 42% and methotrexate in 33% of patients in another review. [43] [42] The actual rates may be lower still since the data were collected from case series and case reports, increasing the risk of publication bias.\u00a0Other systemic immunomodulators have been reported to benefit PRP in case reports and small case series. These include additional IL17 inhibitors brodalumab\u00a0and bimekizumab;\u00a0the IL23 inhibitors guselkumab,\u00a0risankizumab,\u00a0and tildrakizumab;\u00a0the TNF-alpha inhibitors adalimumab,\u00a0etanercept,\u00a0and infliximab;\u00a0the phosphodiesterase 4 inhibitor apremilast;\u00a0and the JAK inhibitors tofacitinib\u00a0and upadacitinib. [44] [45] [46] [47] [48] [49] [50] [51] [52] [53]"}
{"id": "article-27257_27", "title": "Pityriasis Rubra Pilaris -- Treatment / Management", "content": "Narrow-band UVB phototherapy is rarely helpful for PRP since most patients report photo-exacerbation of their disease, but approximately 10% of patients may respond to phototherapy. [42] [43] Once a patient responds to therapy and resolves the disease, treatment can be discontinued, and many patients will remain clear.", "contents": "Pityriasis Rubra Pilaris -- Treatment / Management. Narrow-band UVB phototherapy is rarely helpful for PRP since most patients report photo-exacerbation of their disease, but approximately 10% of patients may respond to phototherapy. [42] [43] Once a patient responds to therapy and resolves the disease, treatment can be discontinued, and many patients will remain clear."}
{"id": "article-27257_28", "title": "Pityriasis Rubra Pilaris -- Differential Diagnosis", "content": "The differential diagnosis for PRP varies depending on the subtype and progression of the disease. PRP is generally a papulosquamous disorder with the most clinical overlap with psoriasis. Psoriasis has a rare follicular subtype that may be difficult to distinguish from PRP,\u00a0although lack of palmoplantar keratoderma would be a pertinent negative finding in follicular psoriasis. [54] Additional pertinent differentials based on common PRP findings include:", "contents": "Pityriasis Rubra Pilaris -- Differential Diagnosis. The differential diagnosis for PRP varies depending on the subtype and progression of the disease. PRP is generally a papulosquamous disorder with the most clinical overlap with psoriasis. Psoriasis has a rare follicular subtype that may be difficult to distinguish from PRP,\u00a0although lack of palmoplantar keratoderma would be a pertinent negative finding in follicular psoriasis. [54] Additional pertinent differentials based on common PRP findings include:"}
{"id": "article-27257_29", "title": "Pityriasis Rubra Pilaris -- Differential Diagnosis", "content": "Scalp : Early scalp disease of PRP can vary from fine to larger plate-like scale, typically on an erythematous base, and may look similar to\u00a0seborrheic dermatitis or allergic contact dermatitis.", "contents": "Pityriasis Rubra Pilaris -- Differential Diagnosis. Scalp : Early scalp disease of PRP can vary from fine to larger plate-like scale, typically on an erythematous base, and may look similar to\u00a0seborrheic dermatitis or allergic contact dermatitis."}
{"id": "article-27257_30", "title": "Pityriasis Rubra Pilaris -- Differential Diagnosis", "content": "Palmoplantar keratoderma : The characteristic red-orange color and the waxy surface of classic PRP may help to distinguish it from psoriasis, acrokeratosis paraneoplastica (ie, Bazex syndrome), and mycosis fungoides.", "contents": "Pityriasis Rubra Pilaris -- Differential Diagnosis. Palmoplantar keratoderma : The characteristic red-orange color and the waxy surface of classic PRP may help to distinguish it from psoriasis, acrokeratosis paraneoplastica (ie, Bazex syndrome), and mycosis fungoides."}
{"id": "article-27257_31", "title": "Pityriasis Rubra Pilaris -- Differential Diagnosis", "content": "Erythroderma : Many inflammatory diseases become difficult to discriminate when generalized into erythroderma, including PRP, psoriasis, mycosis fungoides, Sezary syndrome, atopic dermatitis, allergic contact dermatitis, drug reactions, paraneoplastic erythroderma, and idiopathic erythroderma. The diagnosis of atypical PRP, in particular, must be used with caution since erythrodermic mycosis fungoides and Sezary syndrome may closely mimic PRP, occasionally even exhibiting characteristic islands of sparing. A pastory of an inflammatory disease may aid the diagnosis, although some individuals with PRP have a personal or family history of psoriasis. A biopsy may be helpful.", "contents": "Pityriasis Rubra Pilaris -- Differential Diagnosis. Erythroderma : Many inflammatory diseases become difficult to discriminate when generalized into erythroderma, including PRP, psoriasis, mycosis fungoides, Sezary syndrome, atopic dermatitis, allergic contact dermatitis, drug reactions, paraneoplastic erythroderma, and idiopathic erythroderma. The diagnosis of atypical PRP, in particular, must be used with caution since erythrodermic mycosis fungoides and Sezary syndrome may closely mimic PRP, occasionally even exhibiting characteristic islands of sparing. A pastory of an inflammatory disease may aid the diagnosis, although some individuals with PRP have a personal or family history of psoriasis. A biopsy may be helpful."}
{"id": "article-27257_32", "title": "Pityriasis Rubra Pilaris -- Differential Diagnosis", "content": "Joint or muscle pain : Arthralgias are common in adult PRP,\u00a0and true inflammatory arthritis is rare but occasionally present. [55] [56] However, Wong-type dermatomyositis should be considered if patients report weakness. Wong-type dermatomyositis is a condition with cutaneous features of both PRP and dermatomyositis and systemic dermatomyositis. [57]", "contents": "Pityriasis Rubra Pilaris -- Differential Diagnosis. Joint or muscle pain : Arthralgias are common in adult PRP,\u00a0and true inflammatory arthritis is rare but occasionally present. [55] [56] However, Wong-type dermatomyositis should be considered if patients report weakness. Wong-type dermatomyositis is a condition with cutaneous features of both PRP and dermatomyositis and systemic dermatomyositis. [57]"}
{"id": "article-27257_33", "title": "Pityriasis Rubra Pilaris -- Prognosis", "content": "PRP is not associated with an increased risk of mortality, although the morbidity and quality of life impact are high, especially in more severe diseases. [27] In spontaneous adult-onset PRP, there is approximately a 50% rate of gradual disease resolution over months to years, with a mean time to resolution of around 3 years. [11] [58] Once resolved, recurrence is rare. The remaining 50% of patients may have life-long disease. Early reports suggested that type I (classical adult onset) PRP has an 81% chance of spontaneous clearing in 3 years, whereas type II (atypical adult onset) PRP has a 20% chance. [10] However, more recent and systematic studies would suggest that this distinction is less clear, and the diagnosis of type II PRP includes the retrospective criterion of persistent disease, making it difficult to predict which patients will improve prospectively.", "contents": "Pityriasis Rubra Pilaris -- Prognosis. PRP is not associated with an increased risk of mortality, although the morbidity and quality of life impact are high, especially in more severe diseases. [27] In spontaneous adult-onset PRP, there is approximately a 50% rate of gradual disease resolution over months to years, with a mean time to resolution of around 3 years. [11] [58] Once resolved, recurrence is rare. The remaining 50% of patients may have life-long disease. Early reports suggested that type I (classical adult onset) PRP has an 81% chance of spontaneous clearing in 3 years, whereas type II (atypical adult onset) PRP has a 20% chance. [10] However, more recent and systematic studies would suggest that this distinction is less clear, and the diagnosis of type II PRP includes the retrospective criterion of persistent disease, making it difficult to predict which patients will improve prospectively."}
{"id": "article-27257_34", "title": "Pityriasis Rubra Pilaris -- Prognosis", "content": "Early childhood onset PRP younger than 2 years is often associated with gene variations, in which case the disease is life-long. Pediatric case series of spontaneous PRP report a complete resolution rate between 43% and 80%. [35] [37] [59]", "contents": "Pityriasis Rubra Pilaris -- Prognosis. Early childhood onset PRP younger than 2 years is often associated with gene variations, in which case the disease is life-long. Pediatric case series of spontaneous PRP report a complete resolution rate between 43% and 80%. [35] [37] [59]"}
{"id": "article-27257_35", "title": "Pityriasis Rubra Pilaris -- Complications", "content": "PRP's quality-of-life impact correlates with the severity of patient-reported symptoms and clinician-reported disease severity. [27] Palmar keratoderma leads to difficulty with fine motor skills, including difficulty using smart screens due to loss of tactile grip. Plantar keratoderma with pain and fissuring leads to difficulty walking. Cutaneous itch, pain, dysesthesia, and the need for frequent emollient application lead to difficulty wearing clothing. These factors can lead to difficulty leaving the home and challenges completing daily home and work duties. [27]", "contents": "Pityriasis Rubra Pilaris -- Complications. PRP's quality-of-life impact correlates with the severity of patient-reported symptoms and clinician-reported disease severity. [27] Palmar keratoderma leads to difficulty with fine motor skills, including difficulty using smart screens due to loss of tactile grip. Plantar keratoderma with pain and fissuring leads to difficulty walking. Cutaneous itch, pain, dysesthesia, and the need for frequent emollient application lead to difficulty wearing clothing. These factors can lead to difficulty leaving the home and challenges completing daily home and work duties. [27]"}
{"id": "article-27257_36", "title": "Pityriasis Rubra Pilaris -- Complications", "content": "Most individuals with moderate-to-severe PRP report a strong mental health impact, including depression, anxiety, embarrassment, loneliness, loss of self-esteem, and memory loss or brain fog. In one study, the risk of passive suicidal ideation was 38% and active suicidal ideation 4% during the course of the disease. Another study reported a 7.3% suicidal ideation rate in the preceding 2 weeks in participants with PRP. [28] For those patients with complete disease resolution, complications are uncommon, although some patients report incomplete hair regrowth and a persistent feeling of memory loss or \"brain fog.\" Cutaneous scarring is not expected. [27]", "contents": "Pityriasis Rubra Pilaris -- Complications. Most individuals with moderate-to-severe PRP report a strong mental health impact, including depression, anxiety, embarrassment, loneliness, loss of self-esteem, and memory loss or brain fog. In one study, the risk of passive suicidal ideation was 38% and active suicidal ideation 4% during the course of the disease. Another study reported a 7.3% suicidal ideation rate in the preceding 2 weeks in participants with PRP. [28] For those patients with complete disease resolution, complications are uncommon, although some patients report incomplete hair regrowth and a persistent feeling of memory loss or \"brain fog.\" Cutaneous scarring is not expected. [27]"}
{"id": "article-27257_37", "title": "Pityriasis Rubra Pilaris -- Consultations", "content": "Dermatology should be consulted expediently when PRP is suspected. Additional consultants should include ophthalmology when ectropion is present and podiatry to manage plantar keratoderma and nail dystrophy. All patients should be queried about their mental health impacts, including suicidal ideation, and offered a referral to a mental health clinician.", "contents": "Pityriasis Rubra Pilaris -- Consultations. Dermatology should be consulted expediently when PRP is suspected. Additional consultants should include ophthalmology when ectropion is present and podiatry to manage plantar keratoderma and nail dystrophy. All patients should be queried about their mental health impacts, including suicidal ideation, and offered a referral to a mental health clinician."}
{"id": "article-27257_38", "title": "Pityriasis Rubra Pilaris -- Deterrence and Patient Education", "content": "PRP has no clear association with lifestyle factors or other underlying health conditions.\u00a0All patients should be given information about the PRP Alliance (PRPAlliance.org), a nonprofit patient-support group founded in 2013. The PRP Alliance maintains a \u201cPRP Survival Guide\u201d written by and for patients with PRP.", "contents": "Pityriasis Rubra Pilaris -- Deterrence and Patient Education. PRP has no clear association with lifestyle factors or other underlying health conditions.\u00a0All patients should be given information about the PRP Alliance (PRPAlliance.org), a nonprofit patient-support group founded in 2013. The PRP Alliance maintains a \u201cPRP Survival Guide\u201d written by and for patients with PRP."}
{"id": "article-27257_39", "title": "Pityriasis Rubra Pilaris -- Pearls and Other Issues", "content": "Key facts that clinicians should bear in mind include:", "contents": "Pityriasis Rubra Pilaris -- Pearls and Other Issues. Key facts that clinicians should bear in mind include:"}
{"id": "article-27257_40", "title": "Pityriasis Rubra Pilaris -- Pearls and Other Issues", "content": "PRP is a cutaneous disorder diagnosed by clinical exam and cutaneous biopsy. There are no blood tests for PRP.", "contents": "Pityriasis Rubra Pilaris -- Pearls and Other Issues. PRP is a cutaneous disorder diagnosed by clinical exam and cutaneous biopsy. There are no blood tests for PRP."}
{"id": "article-27257_41", "title": "Pityriasis Rubra Pilaris -- Pearls and Other Issues", "content": "PRP is rare, and all patients should be directed to the PRP Alliance (PRPAlliance.org) for patient support.", "contents": "Pityriasis Rubra Pilaris -- Pearls and Other Issues. PRP is rare, and all patients should be directed to the PRP Alliance (PRPAlliance.org) for patient support."}
{"id": "article-27257_42", "title": "Pityriasis Rubra Pilaris -- Pearls and Other Issues", "content": "Disease severity is associated with an increasingly negative effect on the quality of life from multiple factors, including cutaneous itch, pain, and dysesthesia; pain and decreased function of the hands and feet from palmoplantar keratoderma; and mental health impacts. All patients should be asked about suicidal ideation and offered a referral to a mental health clinician.", "contents": "Pityriasis Rubra Pilaris -- Pearls and Other Issues. Disease severity is associated with an increasingly negative effect on the quality of life from multiple factors, including cutaneous itch, pain, and dysesthesia; pain and decreased function of the hands and feet from palmoplantar keratoderma; and mental health impacts. All patients should be asked about suicidal ideation and offered a referral to a mental health clinician."}
{"id": "article-27257_43", "title": "Pityriasis Rubra Pilaris -- Pearls and Other Issues", "content": "There are no FDA-approved treatments for PRP. Frequent use of topical emollients is essential for comfort, and topical steroids may be tried, although they are not always helpful. Oral corticosteroids are not effective. The highest efficacy rates were reported in open-label studies of immunomodulation of the IL17 pathway using ixekizumab and secukinumab. Oral retinoids and methotrexate are also commonly used for treatment, although response rates may be lower.", "contents": "Pityriasis Rubra Pilaris -- Pearls and Other Issues. There are no FDA-approved treatments for PRP. Frequent use of topical emollients is essential for comfort, and topical steroids may be tried, although they are not always helpful. Oral corticosteroids are not effective. The highest efficacy rates were reported in open-label studies of immunomodulation of the IL17 pathway using ixekizumab and secukinumab. Oral retinoids and methotrexate are also commonly used for treatment, although response rates may be lower."}
{"id": "article-27257_44", "title": "Pityriasis Rubra Pilaris -- Pearls and Other Issues", "content": "Approximately half of cases of PRP resolve within 3 years, although the range is variable, and many cases are life-long.", "contents": "Pityriasis Rubra Pilaris -- Pearls and Other Issues. Approximately half of cases of PRP resolve within 3 years, although the range is variable, and many cases are life-long."}
{"id": "article-27257_45", "title": "Pityriasis Rubra Pilaris -- Pearls and Other Issues", "content": "There are variants of PRP with atypical presentations, but caution should be taken not to miss mimickers, especially mycosis fungoides, Sezary Syndrome, or paraneoplastic phenomena.", "contents": "Pityriasis Rubra Pilaris -- Pearls and Other Issues. There are variants of PRP with atypical presentations, but caution should be taken not to miss mimickers, especially mycosis fungoides, Sezary Syndrome, or paraneoplastic phenomena."}
{"id": "article-27257_46", "title": "Pityriasis Rubra Pilaris -- Enhancing Healthcare Team Outcomes", "content": "PRP\u00a0is a rare, chronic skin disorder characterized by reddish-orange scaling patches, keratotic follicular papules, and palmoplantar keratoderma. The disorder may be encountered by the primary care clinician at its onset. Clinicians should recognize its distinctive clinical features, consider histopathology for confirmation, and differentiate it from other dermatoses.\u00a0Because there is no laboratory test to make a diagnosis, the patient should be referred to the dermatologist for further workup. Once diagnosed, the treatment can be challenging and is usually managed by a medical dermatologist.", "contents": "Pityriasis Rubra Pilaris -- Enhancing Healthcare Team Outcomes. PRP\u00a0is a rare, chronic skin disorder characterized by reddish-orange scaling patches, keratotic follicular papules, and palmoplantar keratoderma. The disorder may be encountered by the primary care clinician at its onset. Clinicians should recognize its distinctive clinical features, consider histopathology for confirmation, and differentiate it from other dermatoses.\u00a0Because there is no laboratory test to make a diagnosis, the patient should be referred to the dermatologist for further workup. Once diagnosed, the treatment can be challenging and is usually managed by a medical dermatologist."}
{"id": "article-27257_47", "title": "Pityriasis Rubra Pilaris -- Enhancing Healthcare Team Outcomes", "content": "Based on the severity of symptoms, other care team members may include an ophthalmologist and a podiatrist.\u00a0Management involves topical agents, systemic therapies, and supportive care. PRP's variable course and potential for significant impact on patients' quality of life necessitate a tailored,\u00a0interprofessional\u00a0approach. Regular monitoring, patient education, and adaptive therapeutic strategies are essential for optimizing outcomes in this challenging dermatological condition.\u00a0All team members should be aware of the mental health impact of PRP, and patients should be regularly assessed for depression and suicidal ideation and referred to a mental health clinician as appropriate.", "contents": "Pityriasis Rubra Pilaris -- Enhancing Healthcare Team Outcomes. Based on the severity of symptoms, other care team members may include an ophthalmologist and a podiatrist.\u00a0Management involves topical agents, systemic therapies, and supportive care. PRP's variable course and potential for significant impact on patients' quality of life necessitate a tailored,\u00a0interprofessional\u00a0approach. Regular monitoring, patient education, and adaptive therapeutic strategies are essential for optimizing outcomes in this challenging dermatological condition.\u00a0All team members should be aware of the mental health impact of PRP, and patients should be regularly assessed for depression and suicidal ideation and referred to a mental health clinician as appropriate."}
{"id": "article-27257_48", "title": "Pityriasis Rubra Pilaris -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Pityriasis Rubra Pilaris -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}